Physician profile
Andy Archuleta
NPI 1407417744
$19,307.35
in general payments reported to CMS, 2019-2025
19 companies · $4,229 in 2025
The $4,229 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,658 · 2021: $2,629 · 2022: $2,482 · 2023: $1,084 · 2024: $7,225 · 2025: $4,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,901 · Food and Beverage: $5,638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,900.94 |
| Food and Beverage | $5,638.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,985.47 | 2022-2025 | Prostep, Inbone, Infinity |
| Elite Orthopedics, LLC | $5,340.52 | 2020-2023 | |
| Paragon 28, INC. | $3,173.36 | 2022-2025 | Portfolio, Hammertube Sterile Implant Kits, Apex 3d |
| Arthrex, INC. | $1,078.48 | 2024 | |
| Treace Medical Concepts, INC. | $819.53 | 2023-2025 | |
| Cornerstone Medical Associates, INC. | $437.66 | 2024 | |
| International Life Sciences | $301.85 | 2023-2024 | Flexband |
| Integra Lifesciences Corporation | $264.99 | 2021-2022 | |
| Kerecis Limited | $262.23 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $183.15 | 2022-2025 | Grafix Pl, Stravix Pl, Stravix |
| Biotissue Holdings INC. | $160.44 | 2024 | |
| Depuy Synthes Sales INC. | $101.74 | 2025 | Motoband |
| Melinta Therapeutics, LLC | $38.79 | 2021 | |
| Globus Medical, INC. | $31.65 | 2025 | Senza |
| Abbvie INC. | $29.32 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $28.80 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.37 | 2024 | Entyvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.54 | 2025 | Jublia |
| Kci USA, INC. | $17.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Archuleta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.